HIND Share Price Performance
US$3.44
-10.56 (-75.43%)
Price US$3.44
Share Pricen/a
No recently updated narratives available.
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Cambridge, Massachusetts.